CVRx (CVRX) Cash & Current Investments (2020 - 2026)
CVRx's (CVRX) quarterly Cash & Current Investments came in at $72.3 million in Q1 2026, down 29.58% year-on-year from $102.7 million in Q1 2025, and down 4.5% quarter-over-quarter from $75.7 million in Q4 2025.
CVRx (CVRX) Cash & Current Investments (2020 - 2026) Analysis & Trends
CVRx's Cash & Current Investments history runs 7 years deep, the most recent figure standing at $72.3 million for Q1 2026.
- On a quarterly basis, Cash & Current Investments fell 29.58% year-over-year to $72.3 million in Q1 2026; TTM through Mar 2026 was $72.3 million, a 29.58% decrease from a year earlier, with the FY2025 full-year figure at $75.7 million, down 28.53% from the prior year.
- Cash & Current Investments fell to $72.3 million in Q1 2026 per CVRX's latest filing, from $75.7 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $131.2 million in Q1 2022 and bottomed at $70.4 million in Q2 2024.
- The 5-year median for Cash & Current Investments is $95.0 million (2025), against an average of $95.5 million.
- Biggest YoY gain for Cash & Current Investments was 157.48% in 2022; the steepest drop was 35.65% in 2022.
- Year by year, Cash & Current Investments stood at $106.2 million in 2022, then fell by 14.71% to $90.6 million in 2023, then rose by 16.96% to $105.9 million in 2024, then slipped by 28.53% to $75.7 million in 2025, then fell by 4.5% to $72.3 million in 2026.
- Per Business Quant, the three latest CVRX Cash & Current Investments figures stand at $72.3 million (Q1 2026), $75.7 million (Q4 2025), and $85.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.80 Bn | 125.92 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.37 Bn | 44.70 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.41 Bn | 27.30 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 3.12 Bn |
| 10 | CVRx | 129.67 Mn | 57.37 Mn | 12.88 Mn | 72.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.30 Mn |
| Dec 31, 2025 | 75.71 Mn |
| Sep 30, 2025 | 85.12 Mn |
| Jun 30, 2025 | 95.03 Mn |
| Mar 31, 2025 | 102.67 Mn |
| Dec 31, 2024 | 105.93 Mn |
| Sep 30, 2024 | 100.16 Mn |
| Jun 30, 2024 | 70.40 Mn |
| Mar 31, 2024 | 80.12 Mn |
| Dec 31, 2023 | 90.57 Mn |
| Sep 30, 2023 | 82.99 Mn |
| Jun 30, 2023 | 90.82 Mn |
| Mar 31, 2023 | 103.28 Mn |
| Dec 31, 2022 | 106.19 Mn |
| Sep 30, 2022 | 109.99 Mn |
| Jun 30, 2022 | 121.35 Mn |
| Mar 31, 2022 | 131.18 Mn |
| Dec 31, 2021 | 142.07 Mn |
| Sep 30, 2021 | 170.91 Mn |
| Jun 30, 2021 | 47.13 Mn |